1026 related articles for article (PubMed ID: 21443752)
21. Induction of pluripotent stem cells from adult human fibroblasts by defined factors.
Takahashi K; Tanabe K; Ohnuki M; Narita M; Ichisaka T; Tomoda K; Yamanaka S
Cell; 2007 Nov; 131(5):861-72. PubMed ID: 18035408
[TBL] [Abstract][Full Text] [Related]
22. Heterogeneity of pluripotent marker gene expression in colonies generated in human iPS cell induction culture.
Masaki H; Ishikawa T; Takahashi S; Okumura M; Sakai N; Haga M; Kominami K; Migita H; McDonald F; Shimada F; Sakurada K
Stem Cell Res; 2007 Nov; 1(2):105-15. PubMed ID: 19383391
[TBL] [Abstract][Full Text] [Related]
23. Zic3 enhances the generation of mouse induced pluripotent stem cells.
Declercq J; Sheshadri P; Verfaillie CM; Kumar A
Stem Cells Dev; 2013 Jul; 22(14):2017-25. PubMed ID: 23421367
[TBL] [Abstract][Full Text] [Related]
24. Efficient induction of pluripotent stem cells from granulosa cells by Oct4 and Sox2.
Mao J; Zhang Q; Ye X; Liu K; Liu L
Stem Cells Dev; 2014 Apr; 23(7):779-89. PubMed ID: 24083387
[TBL] [Abstract][Full Text] [Related]
25. Reprogramming of mouse renal tubular epithelial cells to induced pluripotent stem cells.
Wang WW; Wang W; Jiang Y; Han GF; Lu S; Li G; Zhang J
Cytotherapy; 2013 May; 15(5):578-85. PubMed ID: 23415920
[TBL] [Abstract][Full Text] [Related]
26. Neural differentiation of patient specific iPS cells as a novel approach to study the pathophysiology of multiple sclerosis.
Song B; Sun G; Herszfeld D; Sylvain A; Campanale NV; Hirst CE; Caine S; Parkington HC; Tonta MA; Coleman HA; Short M; Ricardo SD; Reubinoff B; Bernard CC
Stem Cell Res; 2012 Mar; 8(2):259-73. PubMed ID: 22265745
[TBL] [Abstract][Full Text] [Related]
27. Reprogramming in vivo produces teratomas and iPS cells with totipotency features.
Abad M; Mosteiro L; Pantoja C; Cañamero M; Rayon T; Ors I; Graña O; Megías D; Domínguez O; Martínez D; Manzanares M; Ortega S; Serrano M
Nature; 2013 Oct; 502(7471):340-5. PubMed ID: 24025773
[TBL] [Abstract][Full Text] [Related]
28. Tbx3 improves the germ-line competency of induced pluripotent stem cells.
Han J; Yuan P; Yang H; Zhang J; Soh BS; Li P; Lim SL; Cao S; Tay J; Orlov YL; Lufkin T; Ng HH; Tam WL; Lim B
Nature; 2010 Feb; 463(7284):1096-100. PubMed ID: 20139965
[TBL] [Abstract][Full Text] [Related]
29. Pluripotent stem cells induced from adult neural stem cells by reprogramming with two factors.
Kim JB; Zaehres H; Wu G; Gentile L; Ko K; Sebastiano V; Araúzo-Bravo MJ; Ruau D; Han DW; Zenke M; Schöler HR
Nature; 2008 Jul; 454(7204):646-50. PubMed ID: 18594515
[TBL] [Abstract][Full Text] [Related]
30. Generation of clinically relevant "induced pluripotent stem" (iPS) cells.
Heffernan C; Sumer H; Verma PJ
J Stem Cells; 2011; 6(3):109-27. PubMed ID: 23264997
[TBL] [Abstract][Full Text] [Related]
31. Oct4 and klf4 reprogram dermal papilla cells into induced pluripotent stem cells.
Tsai SY; Clavel C; Kim S; Ang YS; Grisanti L; Lee DF; Kelley K; Rendl M
Stem Cells; 2010 Feb; 28(2):221-8. PubMed ID: 20014278
[TBL] [Abstract][Full Text] [Related]
32. Emerging methods for preparing iPS cells.
Miyazaki S; Yamamoto H; Miyoshi N; Takahashi H; Suzuki Y; Haraguchi N; Ishii H; Doki Y; Mori M
Jpn J Clin Oncol; 2012 Sep; 42(9):773-9. PubMed ID: 22826352
[TBL] [Abstract][Full Text] [Related]
33. Multilineage-differentiating stress-enduring (Muse) cells are a primary source of induced pluripotent stem cells in human fibroblasts.
Wakao S; Kitada M; Kuroda Y; Shigemoto T; Matsuse D; Akashi H; Tanimura Y; Tsuchiyama K; Kikuchi T; Goda M; Nakahata T; Fujiyoshi Y; Dezawa M
Proc Natl Acad Sci U S A; 2011 Jun; 108(24):9875-80. PubMed ID: 21628574
[TBL] [Abstract][Full Text] [Related]
34. Generation of functional murine cardiac myocytes from induced pluripotent stem cells.
Mauritz C; Schwanke K; Reppel M; Neef S; Katsirntaki K; Maier LS; Nguemo F; Menke S; Haustein M; Hescheler J; Hasenfuss G; Martin U
Circulation; 2008 Jul; 118(5):507-17. PubMed ID: 18625890
[TBL] [Abstract][Full Text] [Related]
35. Rapid and efficient reprogramming of human amnion-derived cells into pluripotency by three factors OCT4/SOX2/NANOG.
Zhao HX; Li Y; Jin HF; Xie L; Liu C; Jiang F; Luo YN; Yin GW; Li Y; Wang J; Li LS; Yao YQ; Wang XH
Differentiation; 2010; 80(2-3):123-9. PubMed ID: 20510497
[TBL] [Abstract][Full Text] [Related]
36. Reprogramming of human somatic cells to pluripotency with defined factors.
Park IH; Zhao R; West JA; Yabuuchi A; Huo H; Ince TA; Lerou PH; Lensch MW; Daley GQ
Nature; 2008 Jan; 451(7175):141-6. PubMed ID: 18157115
[TBL] [Abstract][Full Text] [Related]
37. Cynomolgus monkey induced pluripotent stem cells established by using exogenous genes derived from the same monkey species.
Shimozawa N; Ono R; Shimada M; Shibata H; Takahashi I; Inada H; Takada T; Nosaka T; Yasutomi Y
Differentiation; 2013; 85(4-5):131-9. PubMed ID: 23792767
[TBL] [Abstract][Full Text] [Related]
38. Human-induced pluripotent stem cells produced under xeno-free conditions.
Ross PJ; Suhr ST; Rodriguez RM; Chang EA; Wang K; Siripattarapravat K; Ko T; Cibelli JB
Stem Cells Dev; 2010 Aug; 19(8):1221-9. PubMed ID: 20030562
[TBL] [Abstract][Full Text] [Related]
39. Differentiation of reprogrammed mouse cardiac fibroblasts into functional cardiomyocytes.
Jiang B; Dong H; Li Q; Yu Y; Zhang Z; Zhang Y; Wang G; Zhang Z
Cell Biochem Biophys; 2013 Jun; 66(2):309-18. PubMed ID: 23212180
[TBL] [Abstract][Full Text] [Related]
40. Human mid-trimester amniotic fluid stem cells cultured under embryonic stem cell conditions with valproic acid acquire pluripotent characteristics.
Moschidou D; Mukherjee S; Blundell MP; Jones GN; Atala AJ; Thrasher AJ; Fisk NM; De Coppi P; Guillot PV
Stem Cells Dev; 2013 Feb; 22(3):444-58. PubMed ID: 23050522
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
